These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 32617866)
1. Nanoparticle-mediated macrophage targeting-a new inhalation therapy tackling tuberculosis. Makled S; Boraie N; Nafee N Drug Deliv Transl Res; 2021 Jun; 11(3):1037-1055. PubMed ID: 32617866 [TBL] [Abstract][Full Text] [Related]
2. Promoted Antitumor Activity of Myricetin against Lung Carcinoma Via Nanoencapsulated Phospholipid Complex in Respirable Microparticles. Nafee N; Gaber DM; Elzoghby AO; Helmy MW; Abdallah OY Pharm Res; 2020 Apr; 37(4):82. PubMed ID: 32291520 [TBL] [Abstract][Full Text] [Related]
3. Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment. Almurshedi AS; Aljunaidel HA; Alquadeib B; Aldosari BN; Alfagih IM; Almarshidy SS; Eltahir EKD; Mohamoud AZ Int J Nanomedicine; 2021; 16():2405-2417. PubMed ID: 33814907 [TBL] [Abstract][Full Text] [Related]
4. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin. Pai RV; Jain RR; Bannalikar AS; Menon MD J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162 [TBL] [Abstract][Full Text] [Related]
5. Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery. Song X; Lin Q; Guo L; Fu Y; Han J; Ke H; Sun X; Gong T; Zhang Z Pharm Res; 2015 May; 32(5):1741-51. PubMed ID: 25407545 [TBL] [Abstract][Full Text] [Related]
6. Nanostructured lipid carrier-mediated lung targeted drug delivery system to enhance the safety and bioavailability of clofazimine. Patil TS; Deshpande AS Drug Dev Ind Pharm; 2021 Mar; 47(3):385-393. PubMed ID: 33646851 [TBL] [Abstract][Full Text] [Related]
8. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s). Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192 [TBL] [Abstract][Full Text] [Related]
9. Optimizing the formulation variables for encapsulation of linezolid into polycaprolactone inhalable microspheres using double emulsion solvent evaporation. Sharma Y; Mahar R; Chakraborty A; Nainwal N Tuberculosis (Edinb); 2023 Dec; 143():102417. PubMed ID: 37827017 [TBL] [Abstract][Full Text] [Related]
10. Inhalable chitosan microparticles for simultaneous delivery of isoniazid and rifabutin in lung tuberculosis treatment. Cunha L; Rodrigues S; Rosa da Costa AM; Faleiro L; Buttini F; Grenha A Drug Dev Ind Pharm; 2019 Aug; 45(8):1313-1320. PubMed ID: 30990096 [TBL] [Abstract][Full Text] [Related]
11. Targeting delivery of simvastatin using ICAM-1 antibody-conjugated nanostructured lipid carriers for acute lung injury therapy. Li SJ; Wang XJ; Hu JB; Kang XQ; Chen L; Xu XL; Ying XY; Jiang SP; Du YZ Drug Deliv; 2017 Nov; 24(1):402-413. PubMed ID: 28165814 [TBL] [Abstract][Full Text] [Related]
12. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
13. Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against Sato MR; Oshiro Junior JA; Machado RT; de Souza PC; Campos DL; Pavan FR; da Silva PB; Chorilli M Drug Des Devel Ther; 2017; 11():909-921. PubMed ID: 28356717 [TBL] [Abstract][Full Text] [Related]
14. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S; Ng WK; Tan RB Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358 [TBL] [Abstract][Full Text] [Related]
15. Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy. Li S; Chen L; Wang G; Xu L; Hou S; Chen Z; Xu X; Wang X; Liu F; Du YZ J Nanobiotechnology; 2018 Dec; 16(1):105. PubMed ID: 30594254 [TBL] [Abstract][Full Text] [Related]
16. Inhalation potential of N-Acetylcysteine loaded PLGA nanoparticles for the management of tuberculosis: Puri V; Chaudhary KR; Singh A; Singh C Curr Res Pharmacol Drug Discov; 2022; 3():100084. PubMed ID: 35112077 [TBL] [Abstract][Full Text] [Related]
17. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers. Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970 [TBL] [Abstract][Full Text] [Related]
18. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery. Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691 [TBL] [Abstract][Full Text] [Related]
19. Nanocrystals embedded in chitosan-based respirable swellable microparticles as dry powder for sustained pulmonary drug delivery. Ni R; Zhao J; Liu Q; Liang Z; Muenster U; Mao S Eur J Pharm Sci; 2017 Mar; 99():137-146. PubMed ID: 27988327 [TBL] [Abstract][Full Text] [Related]
20. Carrageenan from red algae: an application in the development of inhalable tuberculosis therapy targeting the macrophages. Rodrigues S; Cunha L; Rico J; Rosa da Costa AM; Almeida AJ; Faleiro ML; Buttini F; Grenha A Drug Deliv Transl Res; 2020 Dec; 10(6):1675-1687. PubMed ID: 32562253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]